Stock Prices
EPIX
Levi & Korsinsky has announced a class action lawsuit against ESSA Pharma Inc. (NASDAQ:EPIX) with a lead plaintiff deadline of March 25, 2025. Investors who suffered losses are encouraged to seek potential recovery under federal securities laws.
Portfolio Pulse from
January 29, 2025 | 9:30 pm
AZN
Levi & Korsinsky has announced a lead plaintiff deadline of February 21, 2025, for a lawsuit involving AstraZeneca PLC (NASDAQ:AZN). Shareholders who suffered losses can seek potential recovery under federal securities laws.
Portfolio Pulse from
January 29, 2025 | 9:30 pm
TSLA
Tesla's stock declined following its fourth-quarter earnings report, which revealed a second consecutive year of declining profits. The company's revenue and sales fell short of estimates, amid CEO Elon Musk's involvement with President Trump's administration and the pursuit of autonomous driving opportunities.
Portfolio Pulse from
January 29, 2025 | 9:30 pm
MU
A class action lawsuit has been filed against Micron Technology, Inc. (NASDAQ:MU) for potential securities law violations. Investors who suffered losses are encouraged to join the suit by March 10, 2025.
Portfolio Pulse from
January 29, 2025 | 9:30 pm
VFC
V.F. Corporation's Q3 2025 earnings show improvement with North Face and Timberland brands, but Vans underperforms. Despite debt reduction from Supreme's sale, the financial impact is minimal. VFC's valuation is optimistic, with limited upside potential.
Portfolio Pulse from
January 29, 2025 | 9:30 pm
NVO
A class action lawsuit has been filed against Novo Nordisk A/S (NVO) with a deadline of March 25, 2025, for investors to join. The lawsuit is related to potential recovery under federal securities laws.
Portfolio Pulse from
January 29, 2025 | 9:30 pm
TSLA
Tesla's fourth-quarter gross profit margin missed analysts' estimates due to financing offers and discounts aimed at boosting demand for its older vehicle models.
Portfolio Pulse from
January 29, 2025 | 9:30 pm
CUBI
Customers Bancorp, Inc. is facing a lawsuit for securities law violations. Investors who suffered losses are encouraged to contact Levi & Korsinsky by January 31, 2025, to discuss potential recovery options.
Portfolio Pulse from
January 29, 2025 | 9:15 pm
SEIC
SEI Investments Company reported strong financial results for Q4 2024, with a 31% increase in EPS, 15% growth in revenue, and a 43% rise in operating income compared to Q4 2023. Operating margins improved to 26%.
Portfolio Pulse from
January 29, 2025 | 9:15 pm
ELDN
Eledon Pharmaceuticals announced its participation in the Guggenheim Securities SMID Cap Biotech Conference, which could increase visibility and investor interest.
Portfolio Pulse from
January 29, 2025 | 9:15 pm
Previous
Next